CAS RN: 475111-38-7
4-(4-CHLORO-6-(2-(DIFLUOROMETHYL)-1H-BENZO[D]IMIDAZOL-1-YL)-1,3,5-TRIAZIN-2-YL)MORPHOLINE
Product Availability
Choose a grade to view its available package options.
4 package records 0 with current stock 1 grade group
Grade
95% (4)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250522
100mg
Out of stock
Inquiry
Batchno.20251103
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
Batchno.20260329
1g
Out of stock
Inquiry
Batchno.20260503
250mg
Out of stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 475111-38-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
475111-38-7 / 4-[4-chloro-6-[2-(difluoromethyl)benzimidazol-1-yl]-1,3,5-triazin-2-yl]morpholine
Standard CAS: 475111-38-7
Multi CAS: No
Basic Information
copy
CAS
475111-38-7 copy
Multi CAS
No copy
Molecular Formula
C15H13CLF2N6O copy
Molecular Weight
366.750000 copy
Exact Mass
366.080743 copy
InChI
InChI=1S/C15H13ClF2N6O/c16-13-20-14(23-5-7-25-8-6-23)22-15(21-13)24-10-4-2-1-3-9(10)19-12(24)11(17)18/h1-4,11H,5-8H2 copy
InChIKey
AJQZNMCGFMDKGJ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
25 copy
Aromatic heavy atom count
15 copy
Fraction Csp3
0.33 copy
Rotatable bonds
3 copy
H-bond acceptors
7 copy
Molar refractivity
87.45 copy
TPSA
68.96 copy
LogP / Solubility
WLOGP
2.64 copy
MLOGP
2.34 copy
XLogP3
3.2 copy
Consensus LogP
2.73 copy
Log S (ESOL)
-4.02 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-4.47 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.59 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.08 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy